Related Experiment Videos
Tryptophan catabolism and T cell responses
Andrew L Mellor1, David Munn, Phillip Chandler
1Program in Molecular Immunology, Institute of Molecular Medicine and Genetics, Department of Medicine, Medical College of Georgia, Augusta, GA 30912, USA. amellor@mail.mcg.edu
Advances in Experimental Medicine and Biology
|June 23, 2004
Summary
Indoleamine 2,3 dioxygenase (IDO) expressing cells deplete tryptophan, inhibiting T cell responses. This tryptophan depletion hypothesis explains immune tolerance in fetal survival, tumor persistence, and persistent infections like HIV.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Cells expressing indoleamine 2,3 dioxygenase (IDO) are crucial for regulating T cell-mediated adaptive immune responses.
- IDO's role in immune regulation is complex and not fully understood, particularly its link to immune tolerance.
Purpose of the Study:
- To present and elaborate on the tryptophan depletion hypothesis as a model for IDO-mediated T cell inhibition.
- To explore the implications of this hypothesis for understanding immunological paradoxes.
Main Methods:
- Discussion of a working model (tryptophan depletion hypothesis).
- Review of experimental evidence supporting the hypothesis.
- Analysis of the model's implications for immune tolerance.
Main Results:
- IDO-expressing cells, especially antigen-presenting cells (APCs), facilitate T cell entry but impede cell cycle progression.
- Tryptophan catabolism by IDO is proposed as the mechanism for blocking T cell proliferation.
- The hypothesis provides a framework for understanding immune tolerance in various physiological and pathological states.
Conclusions:
- The tryptophan depletion hypothesis offers a unifying explanation for IDO's inhibitory effects on T cells.
- This model helps elucidate mechanisms behind fetal tolerance, tumor immune evasion, and the persistence of infections like HIV.
- Further research is warranted to validate and refine the implications of IDO-mediated tryptophan depletion in adaptive immunity.